Roche

Another Precision Step for Roche as Ignyta Drug Heads to Regulators
Xconomy
Mon, 09/24/18 - 03:32 pm
Roche
entrectinib
Ignyta
FDA
non-small cell lung cancer
Roche aims to improve cancer treatments with DNA blood test
Pharmaforum
Mon, 09/24/18 - 09:54 am
Roche
diagnostics
cancer
personalized medicine
solid tumors
FoundationOne Liquid
Roche tackles clinical trial matching challenge
Fierce Biotech
Tue, 09/18/18 - 04:26 pm
Roche
clinical trials
patients
physicians
Roche's Child Arthritis Drug's New Formulation Gets FDA Nod
Yahoo/Zacks.com
Sat, 09/15/18 - 02:19 pm
Roche
Genentech
FDA
Actemra
systematic juvenile idiopathic arthritis
UK ‘less interesting’ to pharma because of Brexit – Roche CEO
Pharmaforum
Fri, 09/14/18 - 11:53 pm
Brexit
Roche
Severin Schwan
UK
Roche CEO Severin Schwan is keeping his hand on the budget ax
Endpoints
Fri, 09/14/18 - 11:51 am
Roche
Genentech
Severin Schwan
R&D
layoffs
reorganization
BIO, Allergan and Roche Call for FDA Flexibility With Patient Experience Data
RAPS.org
Wed, 09/12/18 - 07:16 pm
BIO
Allergan
Roche
FDA
patient experience data
MS Society protests NICE rejection of Ocrevus for primary progressive MS
BioCentury
Mon, 09/10/18 - 12:16 am
NICE
UK
MS
multiple sclerosis
Ocrevus
ocrelizumab
Roche
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
Yahoo/Benzinga
Mon, 09/3/18 - 01:09 pm
Adamis
GSK
Sangamo BioSciences
Roche
Bluebird Bio
ProQR Therapeutics
Geron
Amarin
Palatin
EyeGate
Galactin
Omeros
Atossa Genetics
Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates
Yahoo/Benzinga
Sat, 09/1/18 - 03:38 pm
biotech
FDA
Roche
Tecentriq
GSK
mepolizumab
Teva Pharmaceutical
fremanezumab
Adamis Pharmaceuticals
Symjepi
Insmed
ALIS
Antares
XYOSTED
Eli Lilly
galcanezumab
Pfizer
dacomitinib
Roche reveals haemophilia drug data ahead of label expansion decision
Pharmaforum
Fri, 08/31/18 - 11:51 am
Roche
hemophilia A
FDA
Hemlibra
Affimed and Roche ink $5bn plus cancer immunotherapy deal
Pharmaforum
Tue, 08/28/18 - 10:03 am
Roche
Genentech
Affimed
cancer immunotherapy
drug development
Jumping ahead of AstraZeneca, AbbVie and J&J get a green light to market Imbruvica/Rituxan combo for rare lymphoma
Endpoints
Mon, 08/27/18 - 10:02 am
AbbVie
JNJ
FDA
Imbruvica
Rituxan
Roche
AstraZeneca
non-Hodgkin's lymphoma
Waldenström’s macroglobulinemia
Once lauded for its clinical success, Roche casts off cardio program inclacumab for a mere $2M to Global Blood Therapeutics
Endpoints
Thu, 08/23/18 - 10:11 am
Roche
inclacumab
Global Blood Therapeutics
Roche's Alecensa latest beneficiary of faster China drug approvals
Reuters
Mon, 08/20/18 - 11:37 am
Roche
Alecensa. China
lung cancer
As biosimilars loom, Roche's Genentech plans to lay off 223 staffers in California
Fierce Pharma
Wed, 08/15/18 - 10:28 pm
Roche
Genentech
WARN notice
layoffs
California
US agency to rule on Tecentriq’s most important use
EP Vantage
Wed, 08/15/18 - 11:57 am
Roche
Tecentriq
non-squamous non-small cell lung cancer
FDA
Roche's Xolair, challenged in asthma, wins 'breakthrough' in food allergies
Fierce Pharma
Mon, 08/13/18 - 05:53 pm
Novartis
Roche
Xolair
FDA
food allergies
Drug firms fight US government’s Iraq corruption probe
Pharmaforum
Thu, 08/9/18 - 08:46 pm
Iraq
DOJ
AstraZeneca
Roche
JNJ
GE
Pfizer
Roche is on the “SurePath” for Cervical Cancer Screening with Approval
Medical Devices and Diagnostics Industry
Sat, 08/4/18 - 12:18 pm
Roche
FDA
HPV
SurePath
diagnostics

Pages